Revelle Aesthetics, Inc.

Revelle Aesthetics, Inc. is a medical device company located in Mountain View, California, focused on innovative solutions for women's aesthetic concerns, particularly cellulite reduction. Founded in 2020, the company emerged from ExploraMed, a prominent medtech incubator. Revelle Aesthetics develops precision technologies aimed at addressing the root causes of aesthetic issues, delivering lasting results for women and dependable outcomes for practitioners. The flagship product, Avéli®, is an FDA-cleared, single-use device designed for the long-term reduction of cellulite in the buttocks and thighs of adult females. Avéli allows for the visualization and targeted release of fibrous septa that cause cellulite dimples, with clinical data supporting benefits lasting up to one year. The company emphasizes innovation, clinical efficacy, and practitioner reliability in its offerings, aiming to help women enhance their confidence through advanced solutions. Revelle Aesthetics serves adult female customers and medical practitioners, ensuring effective and clinically validated treatments. The leadership team is committed to fostering a strong company culture centered on impact, collaboration, and progressive solutions.

• Employees 13
• Founded 2020
• Annual Revenue $1000000
• Total Funding $55000000